Vaccination of Triple Negative Breast Cancer Patients

NCT02938442 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Triple Negative Breast Cancer
Breast Neoplasms

Interventions

BIOLOGICAL: P10s-PADRE with MONTANIDE™ ISA 51 VG
DRUG: Doxorubicin
DRUG: Cyclophosphamide
DRUG: Paclitaxel

Sponsor

University of Arkansas